PRAME-directed therapies represent a novel approach in the treatment of advanced melanoma.
|Videos|July 19, 2011
Dana Monroe on Yervoy Side Effect Nurse Self-Education
Author(s)Dana Monroe, RN, BSN
Dana Monroe from San Francisco Oncology Associates on Yervoy Side Effects and How Oncology Nurses Can Self-Educate
Advertisement
Dana Monroe, RN, OCN®, BSN from San Francisco Oncology Associates on Yervoy Side Effect Nurse Self-Education
Advertisement
Related to this article
A research team from Huntsman Cancer Institute at the University of Utah showed a pathway-targeted therapy that could be an effective melanoma treatment.
Faculty convened at an OncLive Scientific Interchange and Workshop to discuss evolving evidence-based decision-making across CSCC.
In case you missed any, check out our recap of the episodes of OncLive On Air that aired in June 2026.
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Bioequivalent Olaparib Across Previously Approved Cancer Indications
2
Alpha DaRT Plus Pembrolizumab Yields 100% ORR in Elderly Recurrent or Metastatic HNSCC
3
Experts Revisit the Most Notable Data in GU Oncology From ASCO 2026
4
Longer-Term Data Help Shape TKI Selection in ROS1+ and ALK+ NSCLC
5